Keep your hands and feet inside at all times! Fans get a taste of what it will be like to ride Cedar Point's new Siren's ...

The numbers are good—600 horsepower, 3.4 seconds to 60, and up to 303 miles of range—but this EV rides and drives like a ...

Learn more about pickup trucks and view truck inventory. Discover the latest truck models. Read truck reviews written by consumers. See which trucks were nominated and which model won the grand prize.

Kavery Nambisan’s new novel, telling a story of religion, caste and gender, shows her at the top of her game ...

When you buy through our links, we may earn a commission. Learn more› By Caira Blackwell and Joanne Chen If you’re a side-sleeper, congratulations! According to the Mayo Clinic, side sleeping ...

Planned bans — such as in Australia — should be replaced with research and resources to educate parents and carers about the best ways to manage their children’s use of social media.

Away from the test track, the lethargy isn't much of an issue. It's most noticeable on the highway or on long uphill grades, when you're looking to bring up your speed just a bit. You press the pedal ...

The best of London for free. Sign up for our email to enjoy London without spending a thing (as well as some options when you’re feeling flush). Our newsletter hand-delivers the best bits to ...

SRS is a simple, high-efficiency, real-time media server supporting RTMP, WebRTC, HLS, HTTP-FLV, HTTP-TS, SRT, MPEG-DASH, and GB28181.

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.

SAN FRANCISCO — Eli Lilly’s chief scientific officer said Monday that the company purchased a cancer drug from the startup Scorpion Therapeutics because Scorpion’s drug appeared better than ...